Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

SELL
$0.6 - $1.53 $87,093 - $222,087
-145,155 Reduced 0.86%
16,764,480 $10.1 Million
Q2 2023

Jul 31, 2023

SELL
$1.05 - $1.63 $57,376 - $89,069
-54,644 Reduced 0.32%
16,909,635 $19.1 Million
Q1 2023

Apr 27, 2023

SELL
$1.2 - $2.73 $350,258 - $796,837
-291,882 Reduced 1.69%
16,964,279 $22.9 Million
Q4 2022

Jan 30, 2023

SELL
$1.71 - $3.61 $32,814 - $69,275
-19,190 Reduced 0.11%
17,256,161 $32.1 Million
Q3 2022

Oct 21, 2022

SELL
$1.9 - $8.63 $459,195 - $2.09 Million
-241,682 Reduced 1.38%
17,275,351 $42.5 Million
Q2 2022

Jul 26, 2022

SELL
$2.13 - $9.01 $2.76 Million - $11.7 Million
-1,294,895 Reduced 6.88%
17,517,033 $42.7 Million
Q1 2022

Apr 27, 2022

SELL
$6.28 - $15.59 $1.17 Million - $2.91 Million
-186,525 Reduced 0.98%
18,811,928 $150 Million
Q4 2021

Feb 02, 2022

BUY
$14.7 - $28.67 $27.5 Million - $53.7 Million
1,873,864 Added 10.94%
18,998,453 $290 Million
Q3 2021

Oct 25, 2021

BUY
$24.31 - $33.6 $54.4 Million - $75.2 Million
2,238,091 Added 15.03%
17,124,589 $487 Million
Q2 2021

Aug 02, 2021

BUY
$26.09 - $40.4 $35 Million - $54.2 Million
1,340,353 Added 9.89%
14,886,498 $502 Million
Q1 2021

Apr 30, 2021

BUY
$33.06 - $56.93 $75.7 Million - $130 Million
2,290,531 Added 20.35%
13,546,145 $518 Million
Q4 2020

Feb 05, 2021

SELL
$39.09 - $57.4 $370,338 - $543,807
-9,474 Reduced 0.08%
11,255,614 $471 Million
Q3 2020

Oct 30, 2020

SELL
$28.43 - $44.67 $27.6 Million - $43.3 Million
-970,261 Reduced 7.93%
11,265,088 $488 Million
Q2 2020

Jul 27, 2020

SELL
$11.71 - $30.29 $9.46 Million - $24.5 Million
-807,792 Reduced 6.19%
12,235,349 $371 Million
Q1 2020

Apr 27, 2020

BUY
$7.64 - $27.5 $22.8 Million - $82.1 Million
2,986,101 Added 29.69%
13,043,141 $178 Million
Q4 2019

Jan 31, 2020

BUY
$15.02 - $20.57 $42.6 Million - $58.3 Million
2,833,454 Added 39.23%
10,057,040 $162 Million
Q3 2019

Oct 31, 2019

BUY
$18.85 - $27.5 $35.9 Million - $52.4 Million
1,905,746 Added 35.84%
7,223,586 $139 Million
Q2 2019

Jul 29, 2019

BUY
$17.37 - $26.27 $73.4 Million - $111 Million
4,222,987 Added 385.71%
5,317,840 $125 Million
Q1 2019

May 08, 2019

BUY
$10.65 - $25.75 $11.7 Million - $28.2 Million
1,094,853 New
1,094,853 $25.6 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.